KOR

e-Article

Efficacy and safety of secukinumab in moderate to severe palmoplantar pustular psoriasis over 148 weeks: Extension of the 2PRECISE study
Document Type
Article
Source
In: Journal of the American Academy of Dermatology. (Journal of the American Academy of Dermatology, February 2021, 84(2):552-554)
Subject
Language
English
ISSN
10976787
01909622